Announce Date | 05/15/2025 |
EPS Normalized Actual | $-1.07 (Beat by $0.43) |
EPS GAAP Actual | $-1.07 (Beat by $0.43) |
Revenue Actual | $1.19663B |
Revenue Surprise | Beat by $1196.63M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $1.67789 |
EPS GAAP Estimate | $1.67789 |
Revenue Estimate | $2.605502245B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 7.42 | 1.49 | 6.5008 | 8.11633 | 1 |
Dec 2028 | 12.22 | 0.9 | 10.66386 | 13.65796 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.69 | -0.69 | 1.19663B | -11.07% | 1196.63M |
FQ4 2024 (Dec 2024) | 0.51 | 0.51 | 1.52124B | -11.89% | 1521.24M |
FQ3 2024 (Sep 2024) | -0.21 | -0.21 | 1.50762B | -22.46% | 1507.62M |
FQ2 2024 (Jun 2024) | 0.0575 | 0.0575 | 1.63543B | -44.55% | 1635.43M |
FQ1 2024 (Mar 2024) | 0.19 | 0.19 | 1.32911B | -28% | 1329.11M |
FQ4 2023 (Dec 2023) | -0.021 | -0.021 | 1.70204B | -15.84% | 1702.04M |
FQ3 2023 (Sep 2023) | 0.33 | 0.33 | 1.84629B | 100% | 1846.29M |
FQ2 2023 (Jun 2023) | 2.62 | 2.62 | 2.36402B | 2.11% | 2364.02M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
1.67789
Consensus Revenue Estimates
2.605502245B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 4.9657 | -- | 4.34341 | 5.83049 | 1 |
FQ3 2027 (Sep 2027) | 0.9159 | -- | 0.80112 | 1.07541 | 1 |
FQ2 2027 (Jun 2027) | 3.2173 | -- | 2.81412 | 3.7776 | 1 |
FQ1 2027 (Mar 2027) | 4.023 | -- | 3.51885 | 4.72362 | 1 |
FQ4 2026 (Oct 2026) | 1.6699 | -- | 1.43529 | 1.86542 | 1 |
FQ3 2026 (Jul 2026) | 1.45631 | -- | 1.25171 | 1.62682 | 1 |
FQ2 2026 (Jun 2026) | 1.45631 | -- | 1.26853 | 1.78045 | 1 |
FQ1 2026 (Mar 2026) | 0.78574 | 187.82 | 0.68443 | 0.96062 | 1 |
FQ4 2025 (Oct 2025) | 1.85788 | 72.55 | 1.59686 | 2.07541 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.42B | -- | 2.19B | 2.75B | 2 |
FQ3 2027 (Sep 2027) | 2.27B | -- | 2.05B | 2.57B | 2 |
FQ2 2027 (Jun 2027) | 2.34B | -- | 2.11B | 2.65B | 2 |
FQ1 2027 (Mar 2027) | 2.41B | -- | 2.18B | 2.73B | 2 |
FQ4 2026 (Oct 2026) | 2.89B | -- | 2.58B | 3.15B | 2 |
FQ3 2026 (Jul 2026) | 2.75B | -- | 2.45B | 3B | 2 |
FQ2 2026 (Jun 2026) | 2.75B | -- | 2.48B | 3.22B | 2 |
FQ1 2026 (Mar 2026) | 1.63B | 26.52 | 1.47B | 1.91B | 2 |
FQ4 2025 (Oct 2025) | 2.73B | 44.27 | 2.43B | 2.98B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.69 | -0.69 | 100% | |
FQ4 2024 (Dec 2024) | 0.51 | 0.51 | 100% | |
FQ3 2024 (Sep 2024) | -0.21 | -0.21 | 100% | |
FQ2 2024 (Jun 2024) | 0.0575 | 0.0575 | 100% | |
FQ1 2024 (Mar 2024) | 0.19 | 0.19 | 100% | |
FQ4 2023 (Dec 2023) | -0.021 | -0.021 | 100% | |
FQ3 2023 (Sep 2023) | 0.33 | 0.33 | 100% | |
FQ2 2023 (Jun 2023) | 2.62 | 2.62 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $1.2B | $1196.63M | 100% |
FQ4 2024 (Dec 2024) | $0B | $1.52B | $1521.24M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.51B | $1507.62M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.64B | $1635.43M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.33B | $1329.11M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.7B | $1702.04M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.85B | $1846.29M | 100% |
FQ2 2023 (Jun 2023) | $0B | $2.36B | $2364.02M | 100% |